Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. May 24, 2022; 13(5): 352-365
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.352
Figure 6
Figure 6 Kaplan-Meier survival curve by surgical status and metastasis status. Median survival for NM+/no surgery was 9 (95%CI: 4-14) mo, NM+/surgery was 54 (95%CI: 34-85) mo, NM-/no surgery was 11 (95%CI: 6-17) mo, and NM-/surgery was 142 (95%CI: 92-NA) mo (P < 0.001).